Cargando…

Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses

Monoclonal antibodies can mediate protection against Ebola virus (EBOV) infection through direct neutralization as well as through the recruitment of innate immune effector functions. However, the antibody functional response following survival of acute EBOV disease has not been well characterized....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunn, Bronwyn M, Roy, Vicky, Karim, Marcus M, Hartnett, Jessica N, Suscovich, Todd J, Goba, Augustine, Momoh, Mambu, Sandi, John Demby, Kanneh, Lansana, Andersen, Kristian G, Shaffer, Jeffrey G, Schieffelin, John S, Garry, Robert F, Grant, Donald S, Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184900/ https://www.ncbi.nlm.nih.gov/pubmed/31301137 http://dx.doi.org/10.1093/infdis/jiz364

Ejemplares similares

Data set on Lassa fever in post-conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2019)

Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
por: Horton, Lucy E., et al.
Publicado: (2020)

Lassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012–2018)
por: Samuels, Robert J., et al.
Publicado: (2021)

Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone
por: Bond, Nell G, et al.
Publicado: (2021)

A medical records and data capture and management system for Lassa fever in Sierra Leone: Approach, implementation, and challenges
por: Shaffer, Jeffrey G., et al.
Publicado: (2019)

Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents
por: Smither, Allison R., et al.
Publicado: (2023)

Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012–2019
por: Shaffer, Jeffrey G., et al.
Publicado: (2021)

Health seeking behavior after the 2013–16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone
por: Koch, Mikaela R., et al.
Publicado: (2021)

Identification of Common CD8(+) T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
por: Sakabe, Saori, et al.
Publicado: (2020)

High crossreactivity of human T cell responses between Lassa virus lineages
por: Sullivan, Brian M., et al.
Publicado: (2020)

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
por: Ackerman, Margaret E., et al.
Publicado: (2016)

Expansion of CD8(+) T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors
por: LaVergne, Stephanie M., et al.
Publicado: (2022)

Measles Vaccination Elicits a Polyfunctional Antibody Response, Which Decays More Rapidly in Early Vaccinated Children
por: Brinkman, Iris D, et al.
Publicado: (2021)

Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection
por: Branco, Luis M, et al.
Publicado: (2011)

Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone()
por: Shantha, Jessica G., et al.
Publicado: (2018)

Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study
por: Grant, Donald S., et al.
Publicado: (2023)

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
por: Boisen, Matthew L., et al.
Publicado: (2018)

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023)

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
por: Branco, Luis M, et al.
Publicado: (2010)

Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone
por: Shantha, Jessica G., et al.
Publicado: (2021)

69 Preliminary Results: Prevalence and Pathophysiologic Mechanisms of Amenorrhea Among Women Survivors of the 2014–2016 Ebola Outbreak in Sierra Leone
por: Zheng, Crystal, et al.
Publicado: (2023)

Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
por: Gunn, Bronwyn M., et al.
Publicado: (2023)

Elevated l-threonine is a biomarker for Lassa fever and Ebola
por: Gale, Trevor V., et al.
Publicado: (2020)

Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa
por: Fairley, Jessica K., et al.
Publicado: (2016)

Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
por: Borrega, Rodrigo, et al.
Publicado: (2021)

Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone
por: Akpogheneta, Onome, et al.
Publicado: (2021)

Lassa fever-induced hearing loss: The neglected disability of hemorrhagic fever
por: Ficenec, Samuel C., et al.
Publicado: (2020)

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol
por: Penfold, Suzanne, et al.
Publicado: (2023)

Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index
por: Larsen, Martin, et al.
Publicado: (2012)

Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
por: Klitting, Raphaëlle, et al.
Publicado: (2022)

Ebola Virus Disease and Pregnancy: A Retrospective Cohort Study of Patients Managed at 5 Ebola Treatment Units in West Africa
por: Henwood, Patricia C., et al.
Publicado: (2017)

Ophthalmic manifestations and vision impairment in Lassa fever survivors
por: Li, Alexa L., et al.
Publicado: (2020)

Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign
por: Nyombayire, Julien, et al.
Publicado: (2022)

Serologic evidence of human orthopoxvirus infections in Sierra Leone
por: MacNeil, Adam, et al.
Publicado: (2011)

Infectious Disease Physician Assessment of Hospital Preparedness for Ebola Virus Disease
por: Polgreen, Philip M., et al.
Publicado: (2015)

Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques
por: de La Vega, Marc Antoine, et al.
Publicado: (2021)

A Review of Hearing Loss Associated with Zika, Ebola, and Lassa Fever
por: Ficenec, Samuel C., et al.
Publicado: (2019)

A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk
por: Keita, Alpha Kabinet, et al.
Publicado: (2019)

Healthcare Workers' Attitudes Toward Patients With Ebola Virus Disease in The United States
por: Narasimhulu, Deepa Maheswari, et al.
Publicado: (2015)

31. Post-ebola Syndrome Presents with Multiple Overlapping Symptom Clusters: Evidence from an Ongoing Cohort Study in Eastern Sierra Leone
por: Himmelfarb, Sarah Talia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5qf20pkd8ao67kbc5evqm2a82q